Multiplan Corp
NYSE:MPLN

Watchlist Manager
Multiplan Corp Logo
Multiplan Corp
NYSE:MPLN
Watchlist
Price: 20.99 USD -9.33% Market Closed
Market Cap: 339.4m USD

Relative Value

The Relative Value of one MPLN stock under the Base Case scenario is 263.36 USD. Compared to the current market price of 20.99 USD, Multiplan Corp is Undervalued by 92%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MPLN Relative Value
Base Case
263.36 USD
Undervaluation 92%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
65
vs Industry
82
Median 3Y
1
Median 5Y
32.4
Industry
2.3
Forward
0.4
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-10.2
Industry
22
Forward
-2.1
vs History
63
vs Industry
52
Median 3Y
5.4
Median 5Y
105.5
Industry
14.3
vs History
vs Industry
6
Median 3Y
-1
Median 5Y
-2.5
Industry
20
vs History
68
vs Industry
20
Median 3Y
4
Median 5Y
28
Industry
2.2
vs History
61
vs Industry
23
Median 3Y
5.6
Median 5Y
36.5
Industry
2.4
Forward
5
vs History
61
vs Industry
32
Median 3Y
7.4
Median 5Y
45
Industry
5
vs History
58
vs Industry
35
Median 3Y
9.1
Median 5Y
53
Industry
11.6
Forward
8.1
vs History
42
vs Industry
8
Median 3Y
48.9
Median 5Y
48.9
Industry
15.9
Forward
36
vs History
57
vs Industry
7
Median 3Y
44.9
Median 5Y
118.1
Industry
14.3
vs History
vs Industry
4
Median 3Y
118.9
Median 5Y
186.1
Industry
18
vs History
68
vs Industry
59
Median 3Y
1
Median 5Y
8.4
Industry
1.8

Multiples Across Competitors

MPLN Competitors Multiples
Multiplan Corp Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Multiplan Corp
NYSE:MPLN
339.8m USD 0.4 -0.2 9.1 48.8
US
Veeva Systems Inc
NYSE:VEEV
45.9B USD 16.1 58.8 49.1 51.7
US
Cerner Corp
LSE:0R00
31.3B USD 5.4 53.1 21.9 43.2
AU
Pro Medicus Ltd
ASX:PME
33.7B AUD 176.8 343.3 240.2 240.2
US
Doximity Inc
NYSE:DOCS
11.6B USD 20.4 52.1 44.5 46.5
JP
M3 Inc
TSE:2413
1.2T JPY 4.4 30.6 17.4 20.9
SE
Sectra AB
STO:SECT B
70.3B SEK 34 124.8 -154 -154
US
Waystar Holding Corp
NASDAQ:WAY
6.6B USD 6.8 254.4 23.1 49.5
US
Inspire Medical Systems Inc
NYSE:INSP
3.8B USD 4.6 57.7 59.2 69.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
22.5B CNY 8.4 287.6 100.7 100.7
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
266B INR 0 0 0 0
P/E Multiple
Earnings Growth PEG
US
Multiplan Corp
NYSE:MPLN
Average P/E: 140.3
Negative Multiple: -0.2
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
58.8
32%
1.8
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
343.3
38%
9
US
Doximity Inc
NYSE:DOCS
52.1
17%
3.1
JP
M3 Inc
TSE:2413
30.6
N/A N/A
SE
Sectra AB
STO:SECT B
124.8
16%
7.8
US
W
Waystar Holding Corp
NASDAQ:WAY
254.4
N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
57.7
36%
1.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
287.6
N/A N/A
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Multiplan Corp
NYSE:MPLN
Average EV/EBITDA: 62.8
9.1
7%
1.3
US
Veeva Systems Inc
NYSE:VEEV
49.1
38%
1.3
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
240.2
38%
6.3
US
Doximity Inc
NYSE:DOCS
44.5
21%
2.1
JP
M3 Inc
TSE:2413
17.4
13%
1.3
SE
Sectra AB
STO:SECT B
Negative Multiple: -154 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
23.1
18%
1.3
US
Inspire Medical Systems Inc
NYSE:INSP
59.2
90%
0.7
CN
Winning Health Technology Group Co Ltd
SZSE:300253
100.7
48%
2.1
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Multiplan Corp
NYSE:MPLN
Average EV/EBIT: 74.6
48.8
19%
2.6
US
Veeva Systems Inc
NYSE:VEEV
51.7
39%
1.3
US
C
Cerner Corp
LSE:0R00
43.2
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
240.2
36%
6.7
US
Doximity Inc
NYSE:DOCS
46.5
22%
2.1
JP
M3 Inc
TSE:2413
20.9
N/A N/A
SE
Sectra AB
STO:SECT B
Negative Multiple: -154 N/A N/A
US
W
Waystar Holding Corp
NASDAQ:WAY
49.5
40%
1.2
US
Inspire Medical Systems Inc
NYSE:INSP
69.6
64%
1.1
CN
Winning Health Technology Group Co Ltd
SZSE:300253
100.7
47%
2.1
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A